Publicacións nas que colabora con Isabel Badell Serra (19)

2021

  1. Next-generation Sequencing in Bone Marrow Failure Syndromes and Isolated Cytopenias: Experience of the Spanish Network on Bone Marrow Failure Syndromes

    HemaSphere, Vol. 5, Núm. 4

2020

  1. Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic

    Pediatric Blood and Cancer

2011

  1. Chromosome fragility in patients with Fanconi anaemia: Diagnostic implications and clinical impact

    Journal of Medical Genetics, Vol. 48, Núm. 4, pp. 242-250

  2. Origin, functional role, and clinical impact of fanconi anemia fanca mutations

    Blood, Vol. 117, Núm. 14, pp. 3759-3769

2009

  1. Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from fanconi anemia patients

    Molecular Therapy, Vol. 17, Núm. 6, pp. 1083-1092

2007

  1. A comprehensive strategy for the subtyping of patients with Fanconi anaemia: Conclusions from the Spanish Fanconi Anemia Research Network

    Journal of Medical Genetics, Vol. 44, Núm. 4, pp. 241-249

2006

  1. A simplified approach to improve the efficiency and safety of ex vivo hematopoietic gene therapy in fanconi anemia patients

    Human Gene Therapy, Vol. 17, Núm. 2, pp. 245-250

2005

  1. Long-term outcome of allogeneic PBSC transplantation in pediatric patients with hematological malignancies: A report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON) and the Spanish Group for Allogeneic Peripheral Blood Transplantation (GETH)

    Bone Marrow Transplantation, Vol. 36, Núm. 9, pp. 781-785

  2. Long-term outcome of allogeneic or autologous haemopoietic cell transplantation for acute lymphoblastic leukaemia in second remission in children. GETMON experience 1983-1998

    Bone Marrow Transplantation, Vol. 35, Núm. 9, pp. 895-901

2002

  1. Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia

    Bone Marrow Transplantation, Vol. 30, Núm. 1, pp. 9-13

  2. Second allogeneic hematopoietic stem cell transplantation in hematologic malignancies in children: Long-term results of a multicenter study of the spanish working party for bone marrow transplantation in children (GETMON)

    Haematologica, Vol. 87, Núm. 3, pp. 331-332

2000

  1. High survival rate in infant acute leukemia treated with early high-dose chemotherapy and stem-cell support

    Journal of Clinical Oncology, Vol. 18, Núm. 18, pp. 3256-3261

  2. Trasplante de progenitores hematopoyéticos de sangre de cordón umbilical en niños

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 53, Núm. 6, pp. 513-519

  3. Trasplante de progenitores hematopoyéticos de sangre de cordón umbilical en niños

    Anales Espanoles de Pediatria, Vol. 53, Núm. 6, pp. 513-519

1999

  1. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates engraftment kinetics after allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia

    Haematologica, Vol. 84, Núm. 2, pp. 133-137

  2. Trasplante alogenico de medula osea en ninos con aplasia medular grave adquirida. Resultados a largo plazo

    Anales Espanoles de Pediatria, Vol. 50, Núm. 1, pp. 29-32

1998

  1. Quality of life in young adults having received a BMT during childhood: A GETMON study

    Bone Marrow Transplantation

1996

  1. Trasplante alogénico de medula ósea versus autotrasplante en la leucemia aguda linfoblástica en segunda remisión en 113 niños: Resultados del Grupo Español de Trasplante de Medula Osea en Niños (GETMON)

    Sangre, Vol. 41, Núm. 2, pp. 101-108

1995

  1. G-CSF after autologous bone marrow transplantation for malignant diseases in children

    Bone Marrow Transplantation, Vol. 15, Núm. 3, pp. 349-351